Mayo Clinic and IBM today announced plans to pilot Watson, the IBM cognitive computer, to match patients more quickly with appropriate clinical trials, beginning with research studies in cancer. A proof-of-concept phase is currently underway.
“In an area like cancer —where time is of the essence — the speed and accuracy that Watson offers will allow us to develop an individualized treatment plan more efficiently so we can deliver exactly the care that the patient needs,” says Steven Alberts, M.D., chair of medical oncology at Mayo Clinic.
Researchers hope the increased speed also will speed new discoveries.
Clinical trials provide patients with access to new and emerging treatments, yet enrolling participants in trials is one of the more difficult parts of clinical research. Currently it is done manually, with clinical coordinators sorting through patient records and conditions, trying to match them with the requirements of a given study protocol. At any given time, Mayo Clinic is conducting over 8,000 human studies in addition to the 170,000 that are ongoing worldwide. Watson’s cognitive computing ability will help sift through available Mayo clinical trials and ensure that more patients are accurately and consistently matched with promising clinical trial options.
“With shorter times from initiation to completion of trials, our research teams will have the capacity for deeper, more complete investigations,” says Nicholas LaRusso, M.D., a Mayo Clinic gastroenterologist and the project lead for the Mayo-IBM Watson collaboration. “Coupled with increased accuracy, we will be able to develop, refine and improve new and better techniques in medicine at a higher level.”
This version of Watson will be especially designed for Mayo Clinic. As it progresses in its tasks and matures through this collaboration, it will learn more about the clinical trials matching process, become even more efficient and likely more generalizable. Watson also may help locate patients for hard-to-fill trials, such as those involving rare diseases.
The Latest on: Clinical trial research
via Google News
The Latest on: Clinical trial research
- We need to prioritize outpatient clinical trials of drugs against the coronaviruson May 13, 2020 at 4:18 am
Outpatient clinical trials offer the shortest path to end the current lockdowns. If successful, they could help us resume normal activities by transforming the coronavirus into a mild disease that can ...
- The U.S. Navy's Fast-Attack Submarine USS Missouri Heads for Sea Trialson May 13, 2020 at 4:05 am
This week the U.S. Navy’s USS Missouri (SSN 780), a Virginia-class fast-attack submarine, departed the Pearl Harbor naval Shipyard for sea trials after completing a scheduled extended dry-docking ...
- Coronavirus drugs trials must get bigger and more collaborativeon May 13, 2020 at 2:12 am
Researchers have rallied in unprecedented ways to defeat the coronavirus pandemic. They are retooling laboratories to focus on the virus; helping with testing efforts; and, in the case of ...
- Coronavirus has halted criminal trials in Georgia; what does that mean for jury duty?on May 13, 2020 at 2:00 am
With criminal trials in Georgia already halted now for nearly two months at the outset of the coronavirus crisis, it likely will be late summer at the earliest before cases requir ...
- HashCash Plans to Streamline Clinical Trials with Proposed Pharma Consortiumon May 13, 2020 at 12:00 am
HashCash Consultants to focus on streamlining the clinical research and trial process with the help of blockchain by working together with the company's previously ...
- 20th Anniversary Of Week Susie & “The Thorpedo” Headlined Australia’s 2000 Olympic Swim Trialson May 12, 2020 at 10:56 pm
It was a magical time for swimming in Australia – one week in May in the year 2000 when 665 swimmers gathered in Sydney, some seven years after Juan Antonio ...
- After positive results in Seattle, COVID-19 vaccine will face key trials this summer, Moderna CEO sayson May 12, 2020 at 8:16 pm
The coronavirus vaccine trial that started out in Seattle is progressing well enough to get onto Food and Drug Administration’s fast track for development.
- Pfizer wants to expand human trials of coronavirus vaccine to thousands of people by September, CEO sayson May 12, 2020 at 6:00 pm
The U.S.-based pharmaceutical giant, which is working alongside German drugmaker BioNTech, last week dosed its first participants in the United States with a potential Covid-19 vaccine.
- GreenLight Biosciences raises $17M to ramp mRNA production for COVID-19 vaccine candidate trialson May 12, 2020 at 3:57 pm
One of the approaches therapeutics companies are taking to developing vaccines for COVID-19 relies on what's called an mRNA (messenger RNA, which essentially provides cells with protein production ...
- COVID-19 Daily: Fauci Testifies, HCQ Trials Lack ECGon May 12, 2020 at 3:40 pm
While noting that plans to produce doses of COVID-19 vaccine candidates will be undertaken "at risk," in advance of approval to allow speedy distribution, National Institute of Allergy and Infectious ...
via Bing News